Hind Rectifiers Ltd. — Capital/Financing Update 2018

Nov 5, 2018

==> picture [40 x 3] intentionally omitted <==

	1The amount & percentage ofthe turnover orNet Turnover ofthe.division'revenue or income and net worthRs. 4.25 crorescontributed by such unit or division ofthePercentage contribute tolisted entity dl‘Jring the last financial yearTurnover in 2017-18.-'3.38 %2Date of which the agreement of sale has30.10.2018been entered into3The expected date of completion of80.11.2018 subjecttosale/disposalreceipt offull payment &advice/clearance fromCompany’s tax/legalconsultant.'	1The amount & percentage ofthe turnover orNet Turnover ofthe.division'revenue or income and net worthRs. 4.25 crorescontributed by such unit or division ofthePercentage contribute tolisted entity dl‘Jring the last financial yearTurnover in 2017-18.-'3.38 %2Date of which the agreement of sale has30.10.2018been entered into3The expected date of completion of80.11.2018 subjecttosale/disposalreceipt offull payment &advice/clearance fromCompany’s tax/legalconsultant.'
	4Consideration received from such saleTotal consideration will be/disposal-1.95 crores, received 10 lacsadvance on 31.10.20185Brief details of Buyers and whether any ofHemp Pharma Amro Pvt Ltd.
	the buyerslbelong to theNone Ofthe buyer belongspromoter/promotergroup/groupto promoter/promotercompanies. If yes details thereofgroup/group companies.6Whether transaction will fall within relatedNoparty transaction? if yes, whether the same'is done at arm’s length7Rationale for proposed saleAfter expansion at Nasikplant, sufficient capacity isavailable with the companyaccordingly the Boardproposed to sell the surplusassets.8In case of cash consideration- amount orConsideration amount isotherwise-share exchange ratio, brief details1.95 croresofchange in shareholding pattern (ifany) oflisted entity